{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:18:22Z","timestamp":1762867102287},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"JSPS","doi-asserted-by":"publisher","award":["15K06876","15K08364"],"award-info":[{"award-number":["15K06876","15K08364"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.bbrc.2017.04.102","type":"journal-article","created":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T04:31:25Z","timestamp":1492662685000},"page":"613-618","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Angiotensin-converting enzyme 2 is a potential therapeutic target for EGFR -mutant lung adenocarcinoma"],"prefix":"10.1016","volume":"487","author":[{"given":"Miki","family":"Yamaguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachie","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Sumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Tada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukari","family":"Nishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gen","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Sakuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2017.04.102_bib1","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nrc2947","article-title":"Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer","volume":"10","author":"Pao","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2017.04.102_bib2","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/nm.3388","article-title":"The quest to overcome resistance to EGFR-targeted therapies in cancer","volume":"19","author":"Chong","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2017.04.102_bib3","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002003","article-title":"Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors","volume":"3","author":"Sequist","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbrc.2017.04.102_bib4","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/labinvest.2013.102","article-title":"Enhanced autophagy is required for survival in EGFR-independent EGFR-mutant lung adenocarcinoma cells","volume":"93","author":"Sakuma","year":"2013","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbrc.2017.04.102_bib5","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/labinvest.2015.155","article-title":"Prolyl isomerase Pin1 promotes survival in EGFR-mutant lung adenocarcinoma cells with an epithelial-mesenchymal transition phenotype","volume":"96","author":"Sakuma","year":"2016","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbrc.2017.04.102_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4161\/mabs.27022","article-title":"Site-specific antibody drug conjugates for cancer therapy","volume":"6","author":"Panowski","year":"2014","journal-title":"MAbs"},{"key":"10.1016\/j.bbrc.2017.04.102_bib7","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.bbrc.2014.10.133","article-title":"Development of a sensitive screening method for selecting monoclonal antibodies to be internalized by cells","volume":"454","author":"Yamaguchi","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2017.04.102_bib8","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.3892\/ijo.2015.2880","article-title":"A\u00a0newly developed anti-Mucin 13 monoclonal antibody targets pancreatic ductal adenocarcinoma cells","volume":"46","author":"Nishii","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbrc.2017.04.102_bib9","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrcardio.2014.59","article-title":"Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets","volume":"11","author":"Jiang","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.bbrc.2017.04.102_bib10","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.bbrc.2017.04.102_bib11","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A\u00a0crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2017.04.102_bib12","doi-asserted-by":"crossref","first-page":"L84","DOI":"10.1152\/ajplung.00071.2009","article-title":"Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia","volume":"297","author":"Jia","year":"2009","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.bbrc.2017.04.102_bib13","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/labinvest.2012.2","article-title":"Loss of angiotensin-converting enzyme 2 enhances TGF-\u03b2\/Smad-mediated renal fibrosis and NF-\u03baB-driven renal inflammation in a mouse model of obstructive nephropathy","volume":"92","author":"Liu","year":"2012","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbrc.2017.04.102_bib14","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1165\/rcmb.2012-0451OC","article-title":"Angiotensin-converting enzyme 2\/angiotensin-(1-7)\/Mas axis protects against lung fibrosis by inhibiting the MAPK\/NF-\u03baB pathway","volume":"50","author":"Meng","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.bbrc.2017.04.102_bib15","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1038\/ncomms4594","article-title":"Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections","volume":"5","author":"Zou","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2017.04.102_bib16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12974-016-0489-7","article-title":"Angiotensin-converting enzyme 2 activator diminazene aceturate prevents lipopolysaccharide-induced inflammation by inhibiting MAPK and NF-\u03baB pathways in human retinal pigment epithelium","volume":"13","author":"Tao","year":"2016","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.bbrc.2017.04.102_bib17","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2017.04.102_bib18","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/labinvest.2016.135","article-title":"Fibroblastic foci, covered with alveolar epithelia exhibiting epithelial-mesenchymal transition, destroy alveolar septa by disrupting blood flow in idiopathic pulmonary fibrosis","volume":"97","author":"Yamaguchi","year":"2017","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bbrc.2017.04.102_bib19","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/pros.20613","article-title":"Exploration of target molecules for prostate cancer gene therapy","volume":"67","author":"Suzuki","year":"2007","journal-title":"Prostate"},{"key":"10.1016\/j.bbrc.2017.04.102_bib20","first-page":"155","article-title":"Prognostic and predictive factors in breast cancer by immunohistochemical analysis","volume":"11","author":"Allred","year":"1998","journal-title":"Mod. Pathol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X17307775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X17307775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T15:26:08Z","timestamp":1535901968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X17307775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0006291X17307775"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2017.04.102","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin-converting enzyme 2 is a potential therapeutic target for EGFR-mutant lung adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2017.04.102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}